Plea in Delhi HC seeking stay on Phase II/III clinical trial...
Bihar: Covaxin trials on children begin at Patna's AIIMS
Patna (Bihar) [India], June 3 (ANI): Patna's All India Institute of Medical Sciences (AIIMS) has started the...
SC directs Centre to submit complete data on purchase history...
Haffkine Bio-Pharma hopeful of Covaxin production in 8...
Mumbai (Maharashtra) [India], June 2 (ANI): Haffkine Bio-Pharmaceutical Corporation Limited (HBPCL), a...
Mixing of COVID-19 vaccines not protocol yet, clarifies Centre
Delhi left with 3,190 vaccine doses for 18-44 age group
New Delhi [India], May 31 (ANI): Delhi is left with 3,190 COVID vaccine doses in its balance stock out of which...
Bharat Biotech to ramp up production of Covaxin to 10-12...
New Delhi [India], May 31 (ANI): With ramping up of production capacities, nearly 25 crore ‘Made in...
Delhi receives fresh COVID-19 vaccine stock from Centre for 45+
New Delhi [India], May 29 (ANI): Delhi received a fresh stock of COVID-19 vaccine that includes 48,890 doses of...
Covaxin production takes 120 days depending on technology...
New Delhi [India], May 28 (ANI): Amid reports of shortage of its COVID-19 vaccine in the country, Bharat Biotech...
IIL partners with Bharat Biotech to produce drug substance...
Administering two different COVID-19 vaccines under research,...
New Delhi [India], May 28 (ANI): Administering two different COVID-19 vaccines, specially those with similar...
Delhi gets its second drive-through vaccination centre at...
Copyright © aninews.in | All Rights Reserved.